openPR Logo
Press release

Atopic Dermatitis Market 2018 | By Size and Top Industry Players: Astellas Pharma Inc., Sanofi S.A., Regeneron Pharmaceuticals, Etc and Forecast to 2023

06-04-2018 08:47 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Atopic Dermatitis Market

Atopic Dermatitis Market

Market Research Future has a research report on the “Global Atopic Dermatitis Market”. Report included Professional Analysis, information Collected through top Industry Experts interviews and future Growth predictions of Market. This report studies the Global Atopic Dermatitis Market outlook of Global Market 2018. The Atopic Dermatitis Market research report gives Recent trends, Size, Share, Growth information uniquely in depth.

Atopic dermatitis affects a large percentage of the world's population. The skin of a patient with atopic dermatitis becomes dry, red, flaky and very itchy. Although atopic dermatitis can occur at any age, but mostly it affects infants and young children. Occasionally, it may persist in adults as well. Some patients tend to have a protracted course with ups and downs. Mostly, there are periods of time when the disease gets worse, known as exacerbations or flares, which is followed by periods when the skin improves or clears up entirely, called remissions.

Increasing prevalence of skin irritants such as soaps, detergents, perfumes, cosmetics and even water may produce inflammation that may cause the skin to become inflamed. Additionally rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development and rapidly developing technology is expected to fuel the market growth during the forecast period.

The Global Atopic Dermatitis Market is expected to grow at a CAGR of 8.2% during the forecast period 2017-2023.

Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1610 .

Key Players - Atopic Dermatitis Market

Some of key the players in the market are Astellas Pharma Inc. (Japan), Sanofi S.A. (France), Regeneron Pharmaceuticals, Inc. (U.S.), Valeant Pharmaceuticals International, Inc (Canada), Anacor Pharmaceuticals Inc. (U.S.), Novartis International AG (Switzerland), Bristol-Myers Squibb (U.S.), Meda Pharmaceuticals (U.S.), Pfizer Inc. (U.S.), Galderma S.A. (Switzerland), Allergan Plc. (Republic of Ireland)

Regional Analysis - Atopic Dermatitis Market

The Americas dominate the Global Atopic Dermatitis Market owing to the presence of huge patient with skin diseases and infectious disorders, such as staphylococcal and streptococcal bacterial skin infections.

Europe holds the second largest share of the global atopic dermatitis market as result of increasing focus of various government agencies on the treatment of allergic diseases. Moreover, the growing public awareness about atopic dermatitis is likely to boost the European market.

Asia Pacific is the fastest growing atopic dermatitis market across the globe. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development is projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited funds, ignorance of diseases, and poor access to treatment.

Get an Exclusive Discount Report @ https://www.marketresearchfuture.com/check-discount/1610 .

Some Brief Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

TOC Continued….

LIST OF TABLES

Table 1 Atopic Dermatitis Industry Synopsis, 2017-2023

Table 2 Global Atopic Dermatitis Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Atopic Dermatitis Market By Region, 2017-2023, (USD Million)

Table 4 Global Atopic Dermatitis Market By Types, 2017-2023, (USD Million)

Table 5 Global Atopic Dermatitis Market By Application, 2017-2023, (USD Million)

Table 6 Global Atopic Dermatitis Market By End Users, 2017-2023, (USD Million)

Table 7 North America Atopic Dermatitis Market By Types, 2017-2023, (USD Million)

Continued….

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Atopic Dermatitis Market

Figure 3 Segmentation Market Dynamics For Atopic Dermatitis Market

Figure 4 Global Atopic Dermatitis Market Share, By Type 2016

Figure 5 Global Atopic Dermatitis Market Share, By Application 2016

Figure 6 Global Atopic Dermatitis Market Share, By End Users, 2016

Figure 7 Global Atopic Dermatitis Market Share, By Region, 2016

Figure 8 America Atopic Dermatitis Market Share, By Country, 2016

Continued….

Access Complete Report @ https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atopic Dermatitis Market 2018 | By Size and Top Industry Players: Astellas Pharma Inc., Sanofi S.A., Regeneron Pharmaceuticals, Etc and Forecast to 2023 here

News-ID: 1069238 • Views:

More Releases from Market Research Future

Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Companies - Oticon, Demant, Eargo, GN Store Nord
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Compa …
The Hearing Aids Market is experiencing consistent growth as the prevalence of hearing loss increases among both aging and younger populations exposed to noise-related hearing issues. Hearing aids play a critical role in enhancing communication, social interaction, and overall quality of life for individuals with hearing impairment. Advances in digital technology, wireless connectivity, and user-centric designs are further boosting adoption worldwide. Market Overview and Growth Trends As per Market Research Future Analysis,
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2035 with Rapid Technological Adoption
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2 …
The Free Space Optic Communication Market report provides comprehensive insights into market trends, competitive landscape, growth factors, and opportunities across global regions. Free Space Optic Communication Market Overview The Free Space Optic (FSO) Communication Market is witnessing unprecedented growth due to the increasing demand for high-speed, secure, and wireless optical communication solutions. FSO technology uses light to transmit data through free space, offering advantages over traditional fiber-optic and radio frequency communications, particularly
Desiccant Dehumidifier Market Size to Reach USD 1,181.09 Million by 2035 Driven by Industrial and Commercial Demand
Desiccant Dehumidifier Market Size to Reach USD 1,181.09 Million by 2035 Driven …
The Desiccant Dehumidifier Market report provides detailed insights into market trends, competitive landscape, growth factors, and opportunities across global regions. Desiccant Dehumidifier Market Overview The Desiccant Dehumidifier Market is witnessing steady growth due to increasing demand for moisture control in industrial, commercial, and specialized environments. Desiccant dehumidifiers utilize hygroscopic materials to absorb moisture efficiently, making them ideal for low-temperature operations, pharmaceuticals, food processing, and manufacturing facilities. The Desiccant Dehumidifier Market Size was

All 5 Releases


More Releases for Atopic

Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Atopic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The scope of the atopic dermatitis market has experienced substantial expansion recently, projected to increase from $8.61 billion in 2024 to reach $9.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.7%;
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. How Large Will the Atopic Dermatitis Market Size By 2025? The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Atopic Dermatitis Pipeline
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029. Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an